LAS VEGAS, Nov. 11, 2019 /PRNewswire/ -- Centerline Biomedical, Inc. was one of eleven companies selected to present during the Disruptive Technology for Endovascular Therapy sessions during this year\'s Vascular InterVentional Advances (VIVA) meeting. Company CTO Vikash Goel presented the...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ologies-session-300955594.html